Rsm Us Wealth Management »

Allogene Therapeutics shares owned by Rsm Us Wealth Management

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Rsm Us Wealth Management from 13F filings

Historical chart of Rsm Us Wealth Management investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Rsm Us Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Rsm Us Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $51k 39k 1.31

More positions owned by Rsm Us Wealth Management

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Sm Cp Val Etf (VBR)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Vanguard Intl Equity Index Ftse Emr Mkt Etf (VWO)
Microsoft Corporation (MSFT)
Bank of America Corporation (BAC)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)

View all positions for Rsm Us Wealth Management

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Patient Square Capital
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Millennium Management
Two Sigma Investments
Wildcat Capital Management
Two Sigma Advisers
State Street Corporation

View all funds holding Allogene Therapeutics